US Broker Ratings

Gilead Sciences, Inc. (GILD) Stock Analysis: A Solid 8.98% Upside Potential Beckons Investors

Gilead Sciences, Inc. (NASDAQ: GILD), a titan in the healthcare sector, continues to captivate investor interest with its robust portfolio in the drug manufacturing industry. With..

The Cigna Group (CI) Stock Analysis: Investor Outlook with a 24.96% Potential Upside

The Cigna Group (CI), a stalwart in the healthcare sector, continues to capture investor interest with its robust market presence and promising growth outlook. With a..

Humana Inc. (HUM) Stock Analysis: Exploring a 14.45% Potential Upside in the Healthcare Sector

Humana Inc. (NYSE: HUM), a key player in the healthcare plans industry, has captured investor attention with its robust operational framework and an intriguing potential upside..

AstraZeneca PLC (AZN) Stock Analysis: Unveiling a 10.35% Upside Potential in the Healthcare Giant

AstraZeneca PLC (AZN) stands as a prominent player in the healthcare sector, particularly within the general drug manufacturing industry. This biopharmaceutical powerhouse, headquartered in Cambridge, UK,..

Agilent Technologies, Inc. (A) Stock Analysis: Navigating a 2.15% Potential Upside in the Diagnostics & Research Industry

Agilent Technologies, Inc. (NYSE: A), a notable player in the Healthcare sector, specifically in the Diagnostics & Research industry, is currently trading at $146.74 with a..

HCA Healthcare, Inc. (HCA) Stock Analysis: A Leading Player in Healthcare with Limited Upside

HCA Healthcare, Inc. (NYSE: HCA), a titan in the healthcare sector, operates an extensive network of hospitals and healthcare facilities across the United States. With a..

UnitedHealth Group (UNH) Stock Analysis: Exploring an 18.87% Potential Upside for Savvy Investors

As a titan in the healthcare sector, UnitedHealth Group Incorporated (NYSE: UNH) stands at the intersection of medical services and financial acumen. With a sprawling empire..

Alcon Inc. (ALC) Stock Analysis: Insights into a 28.60% Potential Upside in Eye Care Innovation

For investors with an eye on the healthcare sector, Alcon Inc. (NYSE: ALC) presents a compelling opportunity. Specializing in eye care products, Alcon is a Swiss-based..

Bristol-Myers Squibb (BMY) Stock Analysis: Investor Insights on 13.92% Potential Upside

Bristol-Myers Squibb Company (NYSE: BMY) stands as a pillar in the healthcare sector, particularly in the realm of general drug manufacturing. With a robust market capitalization..

Amgen Inc. (AMGN) Stock Analysis: Navigating Growth with Robust Revenue and High ROE

Amgen Inc. (AMGN), a stalwart in the healthcare sector, continues to intrigue investors with its impressive financial metrics and strategic positioning within the drug manufacturing industry...

Thermo Fisher Scientific Inc (TMO) Stock Analysis: A Strong Buy with 7.19% Upside Potential

Thermo Fisher Scientific Inc (NYSE: TMO), a heavyweight in the healthcare sector, continues to be a beacon of innovation and stability in the diagnostics and research..

Abbott Laboratories (ABT) Stock Analysis: Strong Growth Potential with a 14.33% Upside

Abbott Laboratories (NYSE: ABT) continues to stand as a formidable player in the healthcare sector, particularly within the medical devices industry. With a market capitalization of..

Eli Lilly and Company (LLY) Stock Analysis: Robust Growth and Strategic Collaborations Drive Investor Optimism

Eli Lilly and Company (NYSE: LLY) stands as a formidable player in the healthcare sector, particularly within the drug manufacturing industry. With a market capitalization of..

Merck & Company, Inc. (MRK) Stock Analysis: Exploring Its 17.69% Potential Upside

Merck & Company, Inc. (NYSE: MRK), a stalwart in the healthcare sector, commands a formidable presence in the global pharmaceutical landscape. With a market capitalization of..

Septerna, Inc. (SEPN): Biotechnology Stock Poised for a 28.99% Upside — A Consensus Outlook

Septerna, Inc. (NASDAQ: SEPN), a clinical-stage biotechnology company, has been drawing attention from investors with its promising pipeline of oral small molecule products targeting a range..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Exploring a Promising 103.92% Potential Upside

Rapport Therapeutics, Inc. (NASDAQ: RAPP) is catching the eye of investors with its impressive potential upside of 103.92%. Situated in the healthcare sector and specializing in..

MBX Biosciences, Inc. (MBX) Stock Analysis: Potential 138% Upside in Biotech Innovation

MBX Biosciences, Inc. (NASDAQ: MBX), a promising clinical-stage biopharmaceutical company, is capturing attention with its innovative approach to tackling endocrine and metabolic disorders. With a current..

Kamada Ltd. (KMDA) Stock Analysis: Exploring a 111% Potential Upside in the Healthcare Sector

Kamada Ltd. (NASDAQ: KMDA), a prominent player in the healthcare sector, offers investors an intriguing prospect in the realm of specialty and generic drug manufacturing. With..

Celcuity Inc. (CELC) Stock Analysis: Is a 11.19% Upside Within Reach for Biotech Investors?

Celcuity Inc. (NASDAQ: CELC) has been turning heads in the biotechnology sector, with its innovative approach to oncology therapeutics and a significant potential upside of 11.19%...

Cullinan Therapeutics, Inc. (CGEM)

⚠️ No article content returned.

..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds